Lilly’s new diabetes drug doubled sales expectations. It may also be used to treat obesity
admin Eli Lilly & Co. Inc.’s LLY, -2.57% steady transformation into a developer of both cutting-edge…
Read Moredrug
Here’s what the future of ‘high’ society looks like
Legal recreational cannabis dispensaries aren’t open yet in New York state, but cannabis business people…
Read MoreOpinion: American democracy was broken long before the MAGA zealots denied the election and stormed the Capitol
PRINCETON, N.J. (Project Syndicate) – The current mainstream narrative in the United States holds that…
Read More20-year-old investor who made $110 million on a meme stock is pushing for change at a psychedelics company
The 20-year-old investor who found fame this year when he made $110 million trading shares…
Read MoreAstraZeneca says advanced trial of breast-cancer drug Capivasertib meets primary endpoints
AstraZeneca PLC said Wednesday that Capivasertib plus Faslodex significantly improved progression-free survival when compared with…
Read MoreBiogen and Eisai make plans to take another Alzheimer’s drug to the FDA
Biogen Inc. BIIB, -1.93% and Eisai Co. Ltd. 4523, +3.57% are getting closer to a…
Read MoreCanopy Growth speeds up U.S. entry instead of waiting until federal cannabis legalization
Canopy Growth Corp. said Tuesday it will no longer wait until federal legalization to buy…
Read MoreGreen Thumb Industries to sell cannabis at Circle K gas stations in first-of-its-kind deal
Green Thumb Industries Inc. is expanding its reach from the stand-alone dispensary to space at…
Read MoreCannabis legalization goes up for a vote Nov. 8 in five states with a combined adult population of 13 million
Cannabis legalization measures will go before voters in five U.S. states on election day, Nov.…
Read More
Opinion: Investors in drug stocks should ignore dubious valuations based on rigged methodologies
The investment firm Morningstar has announced that it will now pick drug stocks based upon…
Read More